Giuseppe Fraschini

2.7k total citations
53 papers, 2.1k citations indexed

About

Giuseppe Fraschini is a scholar working on Oncology, Cancer Research and Dermatology. According to data from OpenAlex, Giuseppe Fraschini has authored 53 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 16 papers in Cancer Research and 12 papers in Dermatology. Recurrent topics in Giuseppe Fraschini's work include Cancer Treatment and Pharmacology (34 papers), Breast Cancer Treatment Studies (14 papers) and Chemotherapy-related skin toxicity (12 papers). Giuseppe Fraschini is often cited by papers focused on Cancer Treatment and Pharmacology (34 papers), Breast Cancer Treatment Studies (14 papers) and Chemotherapy-related skin toxicity (12 papers). Giuseppe Fraschini collaborates with scholars based in United States, United Kingdom and Italy. Giuseppe Fraschini's co-authors include Gabriel N. Hortobágyi, Aman U. Buzdar, Frankie A. Holmes, Verena Hug, Frederick C. Ames, Richard L. Theriault, Marsha D. McNeese, Vicente Valero, R S Walters and Eleanor D. Montague and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Giuseppe Fraschini

53 papers receiving 2.0k citations

Peers

Countries citing papers authored by Giuseppe Fraschini

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Fraschini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Fraschini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Fraschini more than expected).

Fields of papers citing papers by Giuseppe Fraschini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Fraschini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Fraschini. The network helps show where Giuseppe Fraschini may publish in the future.

Co-authorship network of co-authors of Giuseppe Fraschini

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Fraschini. A scholar is included among the top collaborators of Giuseppe Fraschini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Fraschini. Giuseppe Fraschini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dose-Ranging Trial with a Recombinant Urokinase (Urokinase Alfa) for Occluded Central Venous Catheters in Oncology Patients 2004 ·Journal of Vascular and Interventional Radiology ·Steven R. Deitcher, Giuseppe Fraschini, Jonathan Himmelfarb, Earl Schuman, Thomas J. Smith, Gregory A. Schulz, (unknown), (unknown)	10
2	Fluorouracil, Doxorubicin, and Cyclophosphamide Followed by Tamoxifen as Adjuvant Treatment for Patients with Stage IV Breast Cancer with No Evidence of Disease 2002 ·The Breast Journal ·Edgardo Rivera, Frankie A. Holmes, Aman U. Buzdar, Lina Asmar, Shu‐Wan Kau, Giuseppe Fraschini, (unknown), Richard L. Theriault, Gabriel N. Hortobágyi	43
3	Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy 2000 ·Cancer ·Edgardo Rivera, Frankie A. Holmes, (unknown), Vicente Valero, Richard L. Theriault, Daniel J. Booser, Ronald S. Walters, Aman U. Buzdar, Kapil Dhingra, Giuseppe Fraschini, Gabriel N. Hortobagyi	15
4	Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience 1999 ·Cancer Chemotherapy and Pharmacology ·Nuhad K. Ibrahim, Gabriel N. Hortobágyi, Michael S. Ewer, Mohammed K. Ali, Lina Asmar, Richard L. Theriault, Giuseppe Fraschini, Debra Frye, Aman U. Buzdar	37
5	Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy 1999 ·Cancer Chemotherapy and Pharmacology ·Lajos Pusztai, Frankie A. Holmes, Giuseppe Fraschini, (unknown)	2
6	Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results 1999 ·Annals of Oncology ·Frankie A. Holmes, Vicente Valero, R S Walters, R. Theriault, Daniel J. Booser, Harry Gibbs, Giuseppe Fraschini, A. U. Buzdar, Jie Willey, D. Frye, Lina Asmar, G. N. Hortobágyi	14
7	Secondary drug resistance in breast cancer: Failure to reverse with oral nifedipine 1997 ·International Journal of Cancer ·Frankie A. Holmes, (unknown), Giora M. Mavligit, Giuseppe Fraschini, Debra Frye, Gabriel N. Hortobágyi	4
8	Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer. 1996 ·Journal of Clinical Oncology ·Frankie A. Holmes, Timothy Madden, Robert A. Newman, Vicente Valero, R. Theriault, Giuseppe Fraschini, R S Walters, (unknown), Aman U. Buzdar, Jie Willey, G. N. Hortobágyi	142
9	Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. 1995 ·Journal of Clinical Oncology ·Vicente Valero, Frankie A. Holmes, R S Walters, Richard L. Theriault, Leticia Esparza, Giuseppe Fraschini, Gustavo Fonseca, Robert E. Bellet, Aman U. Buzdar, Gabriel N. Hortobágyi	325
10	Intravascular device-related infections in cancer patients 1995 ·Cancer treatment and research ·Issam Raad, Giuseppe Fraschini	4
11	The Myeloprotective Effect of Recombinant Human Granulocyte-Macrophage Colony-stimulating Factor Given Sequentially with Continuous Infusion Vinblastine in Metastatic Breast Cancer Patients 1993 ·American Journal of Clinical Oncology ·(unknown), Giuseppe Fraschini, Frankie A. Holmes, Debbie Frye, Jordan U. Gutterman, Gabriel N. Hortobágyi	1
12	Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy. 1991 ·Journal of Clinical Oncology ·Giuseppe Fraschini, A. A. Ciociola, Leticia Esparza, D. C. Templeton, (unknown), R S Walters, G. N. Hortobágyi	34
13	Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? 1990 ·Cancer ·Aman U. Buzdar, Marsha D. McNeese, Gabriel N. Hortobágyi, Terry L. Smith, Shu Wan Kau, Giuseppe Fraschini, Verena Hug, Nancy A. Ellerbroek, Frankie A. Holmes, Frederick C. Ames, S. Eva Singletary	49
14	Pirarubicin in Combination Chemotherapy for Metastatic Breast Cancer 1990 ·American Journal of Clinical Oncology ·Gabriel N. Hortobágyi, Richard L. Theriault, D. Frye, R S Walters, Giuseppe Fraschini, Charles K. Tashima, J. Ro, (unknown), A. Buzdar	4
15	Inflammatory carcinoma of the breast: results of a combined-modality approach ? M. D. Anderson Cancer Center experience 1990 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), (unknown), S. Eva Singletary, Marsha D. McNeese, (unknown), Frankie A. Holmes, Giuseppe Fraschini, Verena Hug, (unknown), Charles M. Balch, Gabriel N. Hortobagyi	48
16	Phase II evaluation of gallium nitrate by continuous infusion in breast cancer 1989 ·Investigational New Drugs ·Khaled W. Jabboury, Debbie Frye, Frankie A. Holmes, Giuseppe Fraschini, Gabriel N. Hortobágyi	13
17	Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma 1989 ·Cancer ·Gabriel N. Hortobágyi, D. Frye, Aman U. Buzdar, Michael S. Ewer, Giuseppe Fraschini, Verena Hug, Frederick C. Ames, Eleanor D. Montague, C. H. Carrasco, Brendan J. MacKay, Robert S. Benjamin	149
18	Percutaneous Hepatic Arterial Infusion of Cisplatin-Vinblastine for Refractory Breast Carcinoma Metastatic to the Liver 1988 ·American Journal of Clinical Oncology ·Giuseppe Fraschini, Chusilp Charnsangavej, C. Humberto Carrasco, Aman U. Buzdar, Khaled W. Jabboury, Gabriel N. Hortobágyi	11
19	Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs 1988 ·Cancer ·Aman U. Buzdar, Gabriel N. Hortobágyi, Terry L. Smith, Shu Wan Kau, Connie Marcus, Frankie A. Holmes, Verena Hug, Giuseppe Fraschini, Frederick C. Ames, Richard G. Martin	22
20	Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer. 1987 ·PubMed ·Giuseppe Fraschini, (unknown), Chusilp Charnsangavej, C. H. Carrasco, G. N. Hortobagyi	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact